相关实验视频
Updated: May 5, 2026
05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
5.5K
迪奥斯敏还是赫斯佩里丁? 两种静脉活性黄素在1型糖尿病大鼠中的抗氧化作用的比较
Weronika Borymska1, Sławomir Borymski2, Maria Zych1
1Department of Pharmacognosy and Phytochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.
International journal of molecular sciences
|December 11, 2025
概括
在1型糖尿病中,迪奥斯和赫斯佩里丁表现出中度,剂量依赖的抗氧化作用,赫斯佩里丁更强效. 这些黄素可以通过改善脂质代谢和减少氧化应激来帮助减轻糖尿病并发症.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病和慢性静脉疾病 (CVD) 经常共存,共享氧化压力等病理机制.
- 患有糖尿病的人患心血管疾病的风险更高.
- 氧化应激是糖尿病血管并发症和心血管疾病的关键因素.
研究的目的:
- 为了首次比较diosmin和hesperidin在1型糖尿病中的抗氧化潜力.
- 评估这些黄类药物对糖尿病大鼠的氧化应激标志物和代谢参数的影响.
- 为了确定与剂量相关的疗效和 diosmin 与 hesperidin 的相对效力.
主要方法:
- 治疗1型糖尿病的老鼠用迪奥斯或赫斯佩里丁 (50和100毫克/公斤) 治疗了四周.
- 评估了抗氧化酶的活性 (超氧化脱酶,催化酶,谷氨过氧化酶).
- 测量了硫醇稳态,氧化状态 (TAR,TOS,OSI),氧化损伤 (AOPP,MDA),AGE和代谢标志物.
主要成果:
- 糖尿病诱导了氧化还原稳定性干扰,降低了酶活性和TAR,同时增加了氧化损伤标志物和OSI.
- 黄类药物改善了脂质代谢标志物和降低了AGE,而不会影响血糖.
- 观察到适度的,剂量依赖的抗氧化作用,hesperidin显示出比diosmin更大的功效.
结论:
- 迪奥斯和赫斯佩里丁都表现出互补的作用,包括抗氧化特性,以减轻糖尿病的负面影响.
- 赫斯佩里丁在改善氧化还原状态和代谢参数方面表现出比迪奥斯更强大的效果.
- 这些黄素可以被认为是治疗糖尿病相关并发症的辅助剂.
相关概念视频
01:23Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
01:26Type I Diabetes II: Pathophysiology
121
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
121
01:24Type II Diabetes II: Pathophysiology
36
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36
01:27Diabetic Retinopathy
65
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
65